Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|September 1, 1975
Effect of surfactants on antibiotic resistanceW J Suling, W M O'LearyThe Journal of Antimicrobial Chemotherapy|March 27, 2001
Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitroW J Suling, J A MaddryCanadian Journal of Microbiology|August 1, 1977
Lipids of antibiotic-resistant and -susceptible members of the EnterobacteriaceaeW J Suling, W M O'LearyJournal of the National Cancer Institute|April 1, 1983
Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixtureW J Suling, L S Rice, W M ShannonMutation Research|January 1, 1983
A comparison of the mutagenicity and macromolecular binding of the carcinogens Michler's ketone and reduced Michler's ketoneD J McCarthy, W J Suling, D L HillJournal of Medicinal Chemistry|July 1, 1986
Isolation, synthesis, and antitumor evaluation of spirohydantoin aziridine, a mutagenic metabolite of spirohydantoin mustardR F Struck, M C Kirk, L S Rice, et al.Antimicrobial Agents and Chemotherapy|September 1, 1996
Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studiesE L Wright, D C Quenelle, W J Suling, et al.Biochemical Pharmacology|February 1, 1983
Metabolism of spirohydantoin mustard in the mouse. Isolation of an alkylating, mutagenic metaboliteW J Suling, R F Struck, C W Woolley, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitorsW J Suling, L E Seitz, R C Reynolds, et al.FEMS Microbiology Letters|November 22, 1997
Identification and cloning of the Mycobacterium avium folA gene, required for dihydrofolate reductase activityS Zywno-van Ginkel, T P Dooley, W J Suling, et al.Pageof 3